These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23277150)

  • 1. A bioassay for the detection of neutralizing antibodies against the α-melanocyte stimulating hormone analog afamelanotide in patients with erythropoietic protoporphyria.
    Spichty R; Balimann M; Barman J; Minder EI
    J Pharm Biomed Anal; 2013 Mar; 75():192-8. PubMed ID: 23277150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immunogenicity of the synthetic α-melanocyte-stimulating hormone (α-MSH) analogue afamelanotide ([Nle4-D-Phe7]-α-MSH, Scenesse®) in erythropoietic protoporphyria patients by ELISA detecting both anti-afamelanotide and anti-α-MSH antibodies.
    Lengweiler S; Kreim S; Barman-Aksözen J; Maurer M; Minder EI
    Skin Pharmacol Physiol; 2015; 28(2):103-13. PubMed ID: 25402764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
    Minder EI; Barman-Aksoezen J; Schneider-Yin X
    Clin Pharmacokinet; 2017 Aug; 56(8):815-823. PubMed ID: 28063031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
    Harms JH; Lautenschlager S; Minder CE; Minder EI
    Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.
    Minder EI
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1591-602. PubMed ID: 21073357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Afamelanotide: A Review in Erythropoietic Protoporphyria.
    Kim ES; Garnock-Jones KP
    Am J Clin Dermatol; 2016 Apr; 17(2):179-85. PubMed ID: 26979527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study.
    Minder AE; Barman-Aksoezen J; Schmid M; Minder EI; Zulewski H; Minder CE; Schneider-Yin X
    Ther Adv Rare Dis; 2021; 2():26330040211065453. PubMed ID: 37181106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria.
    Wensink D; Wagenmakers MAEM; Langendonk JG
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):151-160. PubMed ID: 33507118
    [No Abstract]   [Full Text] [Related]  

  • 9. A review and update on melanocyte stimulating hormone therapy: afamelanotide.
    Fabrikant J; Touloei K; Brown SM
    J Drugs Dermatol; 2013 Jul; 12(7):775-9. PubMed ID: 23884489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-MSH tripeptide analogs activate the melanocortin 1 receptor and reduce UV-induced DNA damage in human melanocytes.
    Abdel-Malek ZA; Ruwe A; Kavanagh-Starner R; Kadekaro AL; Swope V; Haskell-Luevano C; Koikov L; Knittel JJ
    Pigment Cell Melanoma Res; 2009 Oct; 22(5):635-44. PubMed ID: 19558415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cholecalciferol and afamelanotide on vitamin D levels in erythropoietic protoporphyria: a multicentre cohort study.
    Kluijver LG; Nekouei Shahraki M; Wagenmakers MAEM; Hanssen BE; Kuerten V; Schelonke K; Homey B; Langendonk JG
    Br J Dermatol; 2024 Aug; 191(3):357-364. PubMed ID: 38634774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-melanocyte-stimulating hormone and endothelin-1 have opposing effects on melanocyte adhesion, migration, and pp125FAK phosphorylation.
    Scott G; Cassidy L; Abdel-Malek Z
    Exp Cell Res; 1997 Nov; 237(1):19-28. PubMed ID: 9417862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retro-inverso α-melanocyte stimulating hormone analog with MC1R-binding selectivity.
    Weeden T; Stefano J; Duan S; Edling A; Hou L; Chuang WL; Perricone MA; Pan C; Dzuris JL
    J Pept Sci; 2011 Jan; 17(1):47-55. PubMed ID: 21171144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanocytes expressing MC1R polymorphisms associated with red hair color have altered MSH-ligand activated pigmentary responses in coculture with keratinocytes.
    Roberts DW; Newton RA; Leonard JH; Sturm RA
    J Cell Physiol; 2008 May; 215(2):344-55. PubMed ID: 17960564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide enhances the sensitivity of alpaca melanocytes to respond to alpha-melanocyte-stimulating hormone by up-regulating melanocortin-1 receptor.
    Dong Y; Cao J; Wang H; Zhang J; Zhu Z; Bai R; Hao H; He X; Fan R; Dong C
    Biochem Biophys Res Commun; 2010 Jun; 396(4):849-53. PubMed ID: 20451493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.
    Minder EI; Schneider-Yin X
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):43-53. PubMed ID: 25470471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-melanocyte stimulating hormone protects retinal pigment epithelium cells from oxidative stress through activation of melanocortin 1 receptor-Akt-mTOR signaling.
    Cheng LB; Cheng L; Bi HE; Zhang ZQ; Yao J; Zhou XZ; Jiang Q
    Biochem Biophys Res Commun; 2014 Jan; 443(2):447-52. PubMed ID: 24316214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of binding activity and biologic effect of a novel alpha-melanocyte-stimulating hormone analogue].
    Ying Y; Lan XP; Tian YP
    Yao Xue Xue Bao; 2007 Mar; 42(3):269-73. PubMed ID: 17520825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria.
    Biolcati G; Marchesini E; Sorge F; Barbieri L; Schneider-Yin X; Minder EI
    Br J Dermatol; 2015 Jun; 172(6):1601-1612. PubMed ID: 25494545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MC1R stimulation by alpha-MSH induces catalase and promotes its re-distribution to the cell periphery and dendrites.
    Maresca V; Flori E; Bellei B; Aspite N; Kovacs D; Picardo M
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):263-75. PubMed ID: 20067588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.